EP300 and breast cancer: In this study, we investigated the mechanisms of action of quercetin for COX-2 suppression in human breast cancer cells and demonstrated that quercetin specifically targeted at p300 signaling pathway to regulate COX-2 expression and COX-2-mediated angiogenesis.